EHRA Premium Access

Sudden death prevention and ICD therapy: unsolved issues

Event: EHRA 2021
Topic: Prevention
Session type: Special Session
Date: 25 April 2021
Time: 15:15 - 16:10

Congress Session

5 presentations in this session

Primary prevention in systolic dysfunction/heart failure patients: use, misuse, and underuse

Speaker: Associate Professor M. Zabel (Gottingen, DE)
Thumbnail

Antitachycardia pacing and VT termination: fact or fancy? What is the impact on shock reduction from a patient's perspective?

Speaker: Doctor U. Birgersdotter-Green (San Diego, US)
Thumbnail

No more therapy delivery after ventricular tachycardia ablation? Will my patient fear shock again?

Speaker: Doctor A. Berruezo Sanchez (Barcelona, ES)
Thumbnail

Noninvasive risk factors for the prediction of inducibility on programmed ventricular stimulation in post-MI patients with ejection fraction over 40% at SCD risk, insights from the PRESERVE EF study

Speaker: Doctor K. Trachanas (Athens, GR)
Thumbnail

Sudden death prevention and ICD therapy: unsolved issues - discussion

Thumbnail

4 speakers from this session

Associate Professor Markus Zabel

Georg-August-University Gottingen/Heart Center, Department of Cardiology, Gottingen (Germany)
4 presentations
0 follower

Doctor Ulrika Birgersdotter-Green

University of California, San Diego, San Diego (United States of America)
3 presentations
0 follower

Doctor Antonio Berruezo Sanchez

Teknon Medical Center, Barcelona (Spain)
14 presentations
0 follower

Doctor Konstantinos Trachanas

, Athens (Greece)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk